NNP
VCYT icon

Nachman Norwood & Parrott’s Veracyte VCYT Stock Holding History

Nachman Norwood & Parrott’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-225
Closed -$7K – 1001
2020
Q3 		$7K Buy
+225
New +$7.15K ﹤0.01% 875

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nachman Norwood & Parrott's VCYT Position: Q4 2020 in Review

Nachman Norwood & Parrott sold out of Veracyte (VCYT) in Q4 2020, closing a stake of 225 shares — an estimated $7K sold.

Nachman Norwood & Parrott first reported a position in VCYT in Q3 2020 and held it in 1 quarter. The position peaked at $7K in Q3 2020. 222 funds tracked by Wall St. Rank hold VCYT as of Q4 2020.

  • Nachman Norwood & Parrott reported no remaining Veracyte position as of Q4 2020 after selling out during the quarter.
  • Nachman Norwood & Parrott sold 225 Veracyte shares in Q4 2020, an estimated $7K.
  • Nachman Norwood & Parrott first reported a position in Veracyte in Q3 2020 and held it in 1 quarter.
  • Nachman Norwood & Parrott's Veracyte position peaked at $7K in Q3 2020.
  • 222 funds tracked by Wall St. Rank held Veracyte as of Q4 2020.

Based on Nachman Norwood & Parrott's 13F filing for Q4 2020, filed 19 Jan 2021.